|
GPATCH4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.47880000362011E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61200999999611E-05 |
| Normal-vs-Stage2 |
5.633700E-04 |
| Normal-vs-Stage3 |
5.53690000515417E-08 |
| Normal-vs-Stage4 |
4.01039999999853E-05 |
| Stage1-vs-Stage2 |
4.444000E-01 |
| Stage1-vs-Stage3 |
2.428100E-02 |
| Stage1-vs-Stage4 |
2.780000E-01 |
| Stage2-vs-Stage3 |
3.726800E-01 |
| Stage2-vs-Stage4 |
8.936800E-01 |
| Stage3-vs-Stage4 |
3.882400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60520000017195E-08 |
| Normal-vs-AfricanAmerican |
1.011860E-04 |
| Normal-vs-Asian |
5.273400E-01 |
| Caucasian-vs-AfricanAmerican |
9.329800E-01 |
| Caucasian-vs-Asian |
2.659200E-01 |
| AfricanAmerican-vs-Asian |
2.444400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.70059998994799E-09 |
| Normal-vs-Female |
4.2610000000054E-05 |
| Male-vs-Female |
1.043830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.130090E-02 |
| Normal-vs-Age(41-60Yrs) |
4.29380000444013E-08 |
| Normal-vs-Age(61-80Yrs) |
2.58740000003144E-06 |
| Normal-vs-Age(81-100Yrs) |
1.345820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.316200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.664000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.865800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.430600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.080400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.428200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.963200E-01 |
| Normal-vs-Grade 2 |
2.58119999996254E-06 |
| Normal-vs-Grade 3 |
1.07750000033491E-08 |
| Normal-vs-Grade 4 |
7.161800E-04 |
| Grade 1-vs-Grade 2 |
5.208200E-01 |
| Grade 1-vs-Grade 3 |
2.545400E-01 |
| Grade 1-vs-Grade 4 |
5.619800E-01 |
| Grade 2-vs-Grade 3 |
1.087050E-01 |
| Grade 2-vs-Grade 4 |
9.263400E-01 |
| Grade 3-vs-Grade 4 |
3.130600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.009410E-04 |
| Normal-vs-ccB subtype |
3.41330000042106E-07 |
| ccA subtype-vs-ccB subtype |
9.165500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01289999615761E-08 |
| Normal-vs-N1 |
6.681600E-01 |
| N0-vs-N1 |
6.968400E-02 |
|
|
